Biochemical Markers of Oxidative Stress in Predialytic Chronic Renal Failure Patients
Article Outline
Background
The present study was designed to test the hypothesis that elevated reactive oxygen species activity and decreased antioxidant activity may contribute to the pathogenesis of chronic renal failure (CRF) which may be aggravated by immunosuppression.
Methods
Thirty healthy controls of either sex in the age group of 25–70 years and 30 age- and sex-matched CRF patients with serum creatinine levels > 3.0 mg/dL were included in the study. Serum malondialdehyde (MDA), adenosine deaminase (ADA), ferric reducing antioxidant power (FRAP), blood urea nitrogen, and creatinine were estimated.
Results
There were statistically significant decreases in predialysis serum ADA and FRAP, and a statistically significant increase in MDA levels in CRF patients compared to controls. MDA showed significant positive correlation with serum creatinine (r = 0.79, p < 0.01). FRAP showed nonsignificant negative correlation with serum creatinine (r = −0.02, p > 0.05). Significant negative correlation was observed between MDA and FRAP (r = −0.55, p < 0.01) in CRF patients. Nonsignificant negative correlation was observed between ADA and MDA (r = −0.0087, p > 0.05), and nonsignificant positive correlation was observed between ADA and FRAP (r = 0.315, p > 0.05) in CRF patients.
Conclusion
These results are suggestive of oxidative stress leading to progressive renal injury along with immunosuppression. FRAP can be a useful indicator to monitor and optimize antioxidant therapy, which may potentially become an important adjunct in the management of CRF patients.
Key words: adenosine deaminase , chronic renal failure , lipid peroxidation , malondialdehyde , total antioxidant capacity
No full text is available. To read the body of this article, please view the PDF online.
References
- High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients . J Am Soc Nephrol . 2001;12:1721–1728
- . The evaluation of oxidative stress in patients with chronic renal failure . Clinica Chimica Acta . 2002;322:157–161
- . Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency . Hypertension . 2002;39:135–141
- . Oxidative stress and chronic renal failure—markers and management . J Nephrol . 2002;15:336–341
- Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study . Clin Chem Lab Med . 2007;45:1211–1218
- . Global assessment of serum antioxidant status in haemodialysis patients . J Nephrol . 2005;18:599–605
- . Renal function and nitrogen metabolites, chapter 35 . In: Ashwood ER editors. Teitz Textbook of Clinical Chemistry . Philadelphia: WB Saunders; 1994;p. 1239–1244
- . The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay . Anal Biochem . 1996;239:70–76
- . Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method . Clinica Chemica Acta . 1978;90:37–43
- . Acute effects of ethanol on production and disposal of adenosine from rat myocardium . Biochem Inter . 1985;10:311–317
- . For ammonia estimation . Clin Chem . 1962;8:130
- Oxidative stress in uremia . Med Res Rev . 2005;25:473–486
- . Lipid peroxidation in patients with chronic renal failure . Rev. Nutr . 1999;12:205–212
- . Methodologies for evaluation of total antioxidant activities in complex mixtures: a critical review . Biol Res . 2001;34:51–73
- . Total and corrected antioxidant capacity in hemodialyzed patients . BMC Nephrol . 2003;4:4
- Erythrocyte susceptibility to oxidative stress in CRF patients under different substitutive treatments . Artif Organs . 2005;29:67–72
- . Endothelium-dependent vasodilation and oxidative stress in chronic renal failure . Kidney Int . 2003;63:50–53
- . Can antioxidant vitamins materially reduce oxidative damage in humans? . Free Radical Biol Med . 1999;26:1034–1053
- . Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency . Kidney Int . 2005;63:179–185
PII: S1561-5413(08)60024-1
doi:10.1016/S1561-5413(08)60024-1
© 2008 The Hong Kong Society of Nephrology. Published by Elsevier Inc. All rights reserved.
